Table 1 Baseline characteristics of the patients according to the seroconversion or not

Age (years)

60.9 ± 12.6

63.1 ± 12.0

56.3 ± 12.6

Sex (Male,%)

54 (56.7)

35 (53.0)

19 (61.3)

Diabetes Mellitus (%)

62 (63.9)

44 (65.7)

18 (60.0)

Body mass index (Kg/m²)

22.7 ± 3.5

22.7 ± 3.6

22.8 ± 3.4

Duration of dialysis (mo)*

41.0 (25–41)

37.5 (22.8-66.3)

53.0 (31.0-82.0)

KT/V

1.44 ± 0.32

1.44 ± 0.33

1.41 ± 0.28

Urea reduction rate (%)

69.3 ± 7.9

70.0 ± 7.8

67.8 ± 8.2

Hepatitis B or C (%)

8 (8.2)

5 (7.5)

3 (10.0)

Medications (%)

Angiotensin converting enzyme inhibitor

18 (18.6)

11 (16.4)

7 (23.3%)

Angiotensin II receptor blocker

60 (61.9)

37 (55.2)

23 (76.7)

Calcium channel blocker

60 (61.9)

41 (61.2)

19 (63.3)

Beta blocker

49 (50.5)

30 (44.8)

19 (63.3)

Diuretics

53 (54.6)

38 (56.7)

15 (50.0)

Statins

40 (42.3)

28 (41.8)

12 (40.0)

Vitamin D analogue

5 (5.2)

4 (6.0)

1 (3.3)

White blood cell (/mm³)

6,450 ± 1,846

6,490 ± 1,977

6,368 ± 1,561

Lymphocyte count (/mm³)

1,376 ± 547

1,432 ± 568

1,225 ± 479

Hemoglobin (g/dL)

10.2 ± 1.1

10.0 ± 1.14

10.5 ± 0.85

MCV (fL)

93.7 ± 5.1

94.4 ± 5.3

91.4 ± 3.6

MCH (pg)

30.9 ± 1.7

31.1 ± 1.7

30.4 ± 1.3

MCHC (g/dL)

33.1 ± 1.1

33.0 ± 1.1

33.2 ± 1.1

Ferritin (ng/mL)*

159 (107–255)

159 (98–255)

155 (108–259)

C-reactive protein (mg/L)*

1.1 (0.5-4.7)

1.1 (0.5-4.3)

2.5 (0.45-6.1)

Glucose (mg/dL)

133 ± 48

134 ± 48

130 ± 48

Uric acid (mg/dL)

7.3 ± 1.3

7.2 ± 1.3

7.4 ± 1.4

Total Cholesterol (mg/dL)

149 ± 35

153 ± 40

149 ± 27

Albumin (g/dL)

4.0 ± 0.4

4.0 ± 0.4

4.0 ± 0.3

Alkaline phosphatase (IU/L)

91 ± 55

84 ± 50

101 ± 62

Total bilirubin (mg/dL)

0.31 ± 0.14

0.32 ± 0.15

0.29 ± 0.12

Triglyceride (mg/dL)

129 ± 94

133 ± 106

117 ± 60

HDL-cholesterol (mg/dL)

38 ± 13

37 ± 13

41 ± 14

Intact-parathyroid hormone (pg/mL)

160 ± 97

148 ± 96

188 ± 97